Kepler Cheuvreux Upgrades Alcon to Hold From Reduce, Adjusts Price Target to $235 From $205
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $115.62
Baird Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $110
Alcon's Strong Market Position and Promising 2025 Product Launches Justify Buy Rating
Stifel Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $100
Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Boston Scientific (BSX)
Wells Fargo Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $105
Alcon Is Maintained at Overweight by Keybanc
KeyBanc Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $107
BTIG Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $106
Alcon Analyst Ratings
UBS Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $110.6
UBS Remains a Buy on Alcon (ALC)
Buy Rating Affirmed: Alcon's Growth Prospects Bolstered by Unity VCS and New Product Pipeline
BTIG Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $104
Alcon Is Maintained at Buy by BTIG
Berenberg Bank Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $110.07
Alcon (ALC) Gets a Buy From Berenberg Bank
Alcon Analyst Ratings
RBC Capital Upgrades Alcon(ALC.US) to Buy Rating, Raises Target Price to $118.36